Authors


Gabi Hanna, MD

Latest:

Moving Toward the Pharmaceutical Industry of the Future with Translational Medicine

Gabi Hanna, MD highlights the need for an effective therapy for acute pancreatitis.


Michael Wilkinson

Latest:

Enabling Digital Transformation: Managing External Clinical Data Sources to Advance Drug Development

With an increasing amount of diverse data that must now be collected and analyzed, the industry is faced with increasingly complex studies that present new challenges in data management.


Aaron Mann

Latest:

Establishing a Basis for Secondary Use Standards for Clinical Trials

Study seeks to understand how different forms of data meet the needs of researchers.


Avacare

Latest:

Clinical Trial Diversity in Action: A Site Roadmap for Sponsors and CROs

Webinar Date/Time: Wed, Oct 30, 2024 11:00 AM EDT


Tom Zietlow, PhD

Latest:

C-Suite Survey Underscores Digital Technology’s Growing Role in Clinical Trials

Findings from the most recent Biopharma Confidence Index show that the pandemic has substantially influenced biopharma executives’ expectations in key areas like artificial intelligence/machine learning and real-world evidence.


Michael DePalma

Latest:

How NLP, OCR, and Social Graphs Accelerate Subject Recruitment for Clinical Trials

Explore how natural language processing and social graph techniques help to tackle the challenge of patient and investigator recruitment and raise the success rate of clinical trials.


Sam Whitaker and Jason Dong

Latest:

Increasing Clinical Trial Diversity Through Patient-First Payment Options

Patient-first trial design, based around the tenets of adaptability and personalization, has emerged as a key solution to increase diversity and improve trial outcomes for all.


Rakshinda Mujeeb, PharmD

Latest:

Clinical Trial Feasibility Observations

Changing the expectations of the feasibility study can improve the process.


Michael Agard

Latest:

Enhancing Trial Master File Quality With Pareto Charts and Funnel Charts

Hidden costs have industry searching for ways to not only identify quality issues, but completely eliminate them from the start.


Sowmyanarayan Srinivasan, Priyanshi Gautam, and Garima Prashad

Latest:

Re-imagining the Labs

Developing a strategic approach for labs that can identify and tackle global health challenges.


Ashley Moultrie, CCRP

Latest:

The Consequences of Underrepresentation in Clinical Trial Design

A representative sample patient population that accurately reflects the overall population is vital to establish the safety and efficacy of a drug.


Neta Bendelac

Latest:

Introducing Sustainability into the Clinical Trial Supply Chain

Identifying areas of burden and steps supply chain operators can take to alleviate them.


Oleksii Korzh, MD, PhD

Latest:

Clinical Trials in Ukraine During the War

Industry must take steps in preserving data for use after the war.


Charles T. Lancaster

Latest:

De-Risking Trials with Science-Driven Oversight

Identifying the ‘significant six’ areas of clinical study conduct to mitigate risk.


Andreas Dreps

Latest:

Overcoming Challenges in the Development of Antibody Drug Conjugates

For antibody drug conjugates to reach their full potential, developers should focus on addressing current challenges such as safety and efficacy.


Kristin Tolbert

Latest:

Pregnant Women: An Underrepresented Group in Clinical Trials

Recent research is showing medical treatment for pregnant women often relies on clinical data from non-pregnant female patient populations.


Cindy Henderson

Latest:

Accelerating Clinical Trial Design and Operations

Fully-integrated, component-based CDMS offers flexibility, customization, and efficiency.


Clint D. Hermes

Latest:

COVID Challenges for Trials in Low-to-Middle-Income Countries

Outlining the five critical hurdles faced by clinical teams conducting studies in these nations amid quarantine and other restrictions.


John R. Nocero, PhD

Latest:

10 Questions to Consider With eTMF Vendor Selection

The many different shapes and sizes of vendors requires a thoughtful process for selection.


Igor Kruglyak

Latest:

How NLP, OCR, and Social Graphs Accelerate Subject Recruitment for Clinical Trials

Explore how natural language processing and social graph techniques help to tackle the challenge of patient and investigator recruitment and raise the success rate of clinical trials.


Patrice Hugo, PhD

Latest:

At-home Self-collection of Blood Specimens for Safety Lab Testing in Clinical Trials via the Tasso+ Device

Laboratory services organization focuses on easing patient and site burden with improved collection device.


Emily Botto

Latest:

Assessing Sponsor Attitudes Toward Retail Pharmacy Involvement in Clinical Trial Recruitment and Execution

Amid CVS’ surprise exit from the clinical research space and the ensuing broader questions, study investigates the benefits of pharmacy chain involvement—along with the concerns and barriers to adoption.


Kaj Stenlöf MD, PhD

Latest:

Using Real-World Data in Patient Recruitment

Growing availability of RWD leads new drug development process.


Evidation

Latest:

How person-centered trial design improves clinical research

Learn how to develop and market products and interventions that actually meet individuals' needs by incorporating patient input exist throughout the trial lifecycle



Melanie Nelson

Latest:

Solutions to Accelerate Data-Driven Chemicals and Materials Innovation

Teams need to keep close track of ingredients, processing parameters, and material performance so that they can use their R&D data to decide exactly which materials to make next.


Paul Ingram, PhD

Latest:

Evaluating Global Regulatory Landscape for Driving Digital Innovation in Supply Management

Recent updates from regulatory bodies are providing more confidence in integrating different forms of trials and technology.


Elaine Lim

Latest:

How Sponsors Can Use Health Decision Science to Improve Clinical Trial Recruitment and Retention

Examining the behaviors of clinical trial stakeholders to better understand challenges in patient participation.



Jill Guary

Latest:

Executing Trial Design With Patients—Not For Patients

Approaching protocol design and operational planning with patient empathy.

© 2025 MJH Life Sciences

All rights reserved.